WHAM (Women’s Health Access Matters) and KPMG have initiated a partnership, amounting to $1.1 million, with the aim of advancing women’s health research and investment. This multiyear collaboration, announced today, seeks to harness the power of data and innovative strategies to accelerate progress in addressing women’s health needs, particularly in autoimmune disease, brain health, cancer, and heart health.
“We are thrilled to announce this transformative partnership with KPMG,” said Carolee Lee, CEO and founder of WHAM. “Together, we are committed to advancing women’s health outcomes by leveraging data-driven strategies and innovative solutions. By combining our expertise, we aim to accelerate progress and ensure that the unique health needs of women are prioritized and addressed, fostering not only healthier communities but also economic prosperity for society.”
“As a global leader with a history of providing innovative business solutions, KPMG is excited to collaborate with WHAM to drive meaningful change in women’s health,” said Ash Shehata, KPMG U.S. sector leader for healthcare. “Through this partnership, we will leverage our technological capabilities and global network to support WHAM’s mission and contribute to improving health outcomes for women.”
The partnership will focus on WHAM’s 3Not30 goals, which include increasing funding for women’s health research and investment, improving access and diversity in clinical trials, and utilizing data to drive evidence-based solutions tailored to women’s needs.
Key initiatives of the partnership include publishing a WHAM report on investment in women’s health, creating a WHAM investment index, and generating a feasibility report for industry-based data mining to analyze treatment efficacy and real-world impact by sex.
As a nonprofit, WHAM serves as a central hub for collaborative efforts in women’s health. By fostering partnerships across diverse sectors, such as this collaboration with KPMG and the KPMG U.S. Foundation, WHAM hopes to unlock substantial growth opportunities in diagnostics, treatments, and prevention, envisioning a future where women’s health receives the attention and resources it deserves.
